How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia?
- 282 Downloads
An increasing emphasis in the schizophrenia literature has been on the prodromal phase of the illness. The study of schizophrenia spectrum illness, including schizotypal personality disorder, has added important insight into the etiology, neuropathology, and treatment of schizophrenia, which can facilitate early identification, intervention, and perhaps prevention of the illness. The heterogeneity of the schizophrenia spectrum makes its definition elusive at best. The primary aim of the Cognitive Assessment and Risk Evaluation Program at the authors’ institution is to combine the current knowledge of clinical and demographic risk factors for schizophrenia with the rapidly emerging data on vulnerability markers, or endophenotypes, that are associated with schizophrenia. The use of brain-based vulnerability markers may help to identify neurobiologically and clinically meaningful subgroups within this heterogeneous population of individuals in the early stages of schizophrenia. Another important aim of the Cognitive Assessment and Risk Evaluation program is to thoroughly assess those individuals who have not converted to psychosis to understand potential protective factors, reduce the rate of false positives, and decrease disability. The current review details a strategy for researching the schizophrenia prodrome by using information gained from research in schizotypal personality disorder.
KeywordsSchizophrenia Negative Symptom Personality Disorder Schizophrenia Spectrum Disorder Schizotypal Personality Disorder
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 4.Yung AR, Phillips LJ, Yuen HP, McGorry PD: Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004, 67:131–142. This article identifies factors that may predict transition to psychosis within a prodromal sample and discusses prevention and treatment strategies.PubMedCrossRefGoogle Scholar
- 12.Miller TJ, McGlashan TH, Rosen JL, et al.: Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002, 159:863–865.PubMedCrossRefGoogle Scholar
- 28.Yung A, Phillips L, et al.: Comprehensive Assessment of At Risk Mental States (CAARMS). Melbourne, Australia. The PACE Clinic, University of Melbourne, Department of Psychiatry, January 2002.Google Scholar
- 31.Avila MT, Adami HM, McMahon RP, Thaker GK: Using neurophysiological markers of genetic risk to define the boundaries of the schizophrenia spectrum phenotype. Schizophr Bull 2003, 29:299–309. The authors examine eye tracking deficits within schizophrenia spectrum patients and their relatives to validate the use of reduced criteria in the identification of high-risk subjects.PubMedGoogle Scholar
- 32.Heaton RK, Grant I, et al.: Demographic Influences on Neuropsychological Test Performance. In Neuropsychological Assessment of Neuropsychiatric Disorders, 2nd Edition. Edited by Grant I, Adams K. New York: Grune & Stratton; 1996.Google Scholar
- 44.Weiser M, Noy S, Kaplan Z, et al.: Generalized cognitive impairment in male adolescents with schizotypal personality disorder. Am J Med Genet 2003, 116B:36–40. This article compares deficits within SPD and schizophrenia patient populations and characterizes generalized cognitive impairment with schizotypal symptoms, and without psychosis, as the central components of schizotaxia.CrossRefPubMedGoogle Scholar